This content is machine translated SGLT2 inhibitors and GLP1-RA Are old, white men favored? Despite consistent recommendations and growing clinical evidence, uptake of SGLT2i and GLP1 RA therapies in people with type 2 diabetes and cardiorenal comorbidities has been slow. There is also relatively...…
